First National Bank of Omaha Takes Position in Humana Inc. $HUM

Key Points

• First National Bank of Omaha purchased 2,766 Humana shares worth approximately $1.1 million during the second quarter, while institutional investors collectively own 92.38% of the company.
• Analyst sentiment remains mixed but generally constructive: Humana has a consensus “Hold” rating and an average price target of $395.22, with recent targets ranging from $300 to $500.
• Humana exceeded quarterly expectations, reporting $7.61 in adjusted earnings per share versus a $7.27 estimate and $40.89 billion in revenue, up 26.2% year over year.

First National Bank of Omaha purchased a new position in shares of Humana Inc. (NYSE:HUM - Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 2,766 shares of the insurance provider's stock, valued at approximately $1,099,000.

Other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. increased its holdings in Humana by 0.7% in the fourth quarter. Vanguard Group Inc. now owns 14,261,860 shares of the insurance provider's stock valued at $3,652,890,000 after purchasing an additional 106,030 shares during the period. BlackRock Inc. acquired a new position in Humana during the 2nd quarter worth about $4,138,160,000. Capital International Investors lifted its holdings in Humana by 113.9% during the 4th quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider's stock worth $1,490,239,000 after buying an additional 3,097,571 shares during the period. Pzena Investment Management LLC grew its position in shares of Humana by 34.3% in the 1st quarter. Pzena Investment Management LLC now owns 5,470,982 shares of the insurance provider's stock valued at $948,614,000 after buying an additional 1,398,774 shares during the last quarter. Finally, State Street Corp grew its position in shares of Humana by 1.8% in the 4th quarter. State Street Corp now owns 5,462,549 shares of the insurance provider's stock valued at $1,403,877,000 after buying an additional 97,211 shares during the last quarter. Institutional investors own 92.38% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on HUM shares. Sanford C. Bernstein reissued an "outperform" rating and issued a $425.00 price target on shares of Humana in a research note on Wednesday, June 3rd. William Blair assumed coverage on Humana in a research note on Wednesday, May 20th. They issued an "outperform" rating on the stock. JPMorgan Chase & Co. upped their target price on Humana from $316.00 to $393.00 and gave the company a "neutral" rating in a report on Monday, August 10th. Bank of America raised shares of Humana from a "neutral" rating to a "buy" rating and set a $500.00 target price for the company in a research report on Wednesday, July 29th. Finally, Cantor Fitzgerald raised their price target on shares of Humana from $264.00 to $300.00 and gave the stock a "neutral" rating in a report on Tuesday, July 7th. Fourteen investment analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $395.22.

Humana Stock Performance

NYSE HUM opened at $377.18 on Thursday. The company has a fifty day simple moving average of $383.16 and a 200 day simple moving average of $279.59. Humana Inc. has a 12-month low of $163.11 and a 12-month high of $428.88. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62. The company has a market cap of $45.29 billion, a P/E ratio of 35.68, a PEG ratio of 2.18 and a beta of 0.72.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, topping the consensus estimate of $7.27 by $0.34. The firm had revenue of $40.89 billion for the quarter, compared to the consensus estimate of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. The business's revenue was up 26.2% on a year-over-year basis. During the same quarter in the prior year, the company posted $6.27 earnings per share. Sell-side analysts predict that Humana Inc. will post 9.08 earnings per share for the current fiscal year.

Humana Company Profile

Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source